Katz P, Fauci A S
Clin Exp Immunol. 1978 Jun;32(3):554-62.
The present study employed a direct plaque-forming cell (PGC) assay following pokeweed mitogen (PWM) induced polyclonal activation of B lymphocytes in sarcoidosis to evaluate the in vitro humoral immune response in this disease and to delineate the immunoregulation of this response. Sarcoidosis lymphocytes had a suppressed PFC response to polyclonal activation, but were unable to suppress normal B-cell PFC responses in allogeneic co-cultures. Removal of a cell type, which was corticosteroid-resistant, radio-resistant, adherent and a non-T cell, from sarcoidosis mononuclear cell suspensions reversed the suppressed PFC response, indicating the presence of a suppressor monocyte. Thus in vitro suppressor cell activity has now been demonstrated in this disease, which is characterized by multiple immunological aberrancies.
本研究采用在结节病中经商陆丝裂原(PWM)诱导B淋巴细胞多克隆激活后的直接空斑形成细胞(PFC)测定法,以评估该疾病的体外体液免疫反应,并阐明这种反应的免疫调节。结节病淋巴细胞对多克隆激活的PFC反应受到抑制,但在同种异体共培养中无法抑制正常B细胞的PFC反应。从结节病单核细胞悬液中去除一种对皮质类固醇耐药、对辐射耐药、贴壁且非T细胞的细胞类型,可逆转受抑制的PFC反应,表明存在抑制性单核细胞。因此,现已在这种以多种免疫异常为特征的疾病中证明了体外抑制细胞活性。